Hatcher M E, Connelly C
School of Business and Administrative Sciences, California State University, Fresno 93740-0007.
J Med Syst. 1988 Dec;12(6):341-63. doi: 10.1007/BF00992684.
The institution of prospective payment systems by many health care insurers has drawn increased attention to case-based financial planning in hospitals. When hospital revenues are directly linked to patient diagnoses rather than to the types and quantities of services supplied to patients, managers must be aware of the financial implications of different case mixes and must be prepared to influence insurers' price structures. A case-based financial planning model is presented here for the purpose of assisting managerial decision making in the strategic areas of case mix planning and pricing. The computerized model characterizes hospitals as product manufacturers, the product being discharged patients. Diagnosis serves to differentiate the "products"; however, diagnoses are grouped by payor and similar treatment cost experiences to create a limited set of managerially meaningful case types. Diagnostic and treatment costs are also aggregated to facilitate the modeling of the hospital production process. The computerized model projects the number of patients of each case-type and total patient volume, based on estimated patient volume growth rates. The model also projects prices and contribution margins for each case-type, as well as total contribution to hospital overhead. Testing the model with a hypothetical example of a hospital strategic planning problem demonstrates the model's potential as a decision-making aid in case mix planning and case-type pricing. It also reveals several model shortcomings that require further developmental effort.
许多医疗保险公司实行的前瞻性支付系统已使医院基于病例的财务规划受到更多关注。当医院收入直接与患者诊断相关联,而非与提供给患者的服务类型和数量相关联时,管理人员必须了解不同病例组合的财务影响,并必须准备好影响保险公司的价格结构。本文提出了一种基于病例的财务规划模型,旨在协助在病例组合规划和定价的战略领域进行管理决策。该计算机化模型将医院描述为产品制造商,产品即为出院患者。诊断用于区分“产品”;然而,诊断按付款人和相似的治疗成本经历进行分组,以创建一组数量有限但对管理有意义的病例类型。诊断和治疗成本也进行汇总,以方便对医院生产过程进行建模。该计算机化模型根据估计的患者数量增长率预测每种病例类型的患者数量和患者总数。该模型还预测每种病例类型的价格和边际贡献,以及对医院间接费用的总贡献。用一个医院战略规划问题的假设示例对该模型进行测试,证明了该模型在病例组合规划和病例类型定价中作为决策辅助工具的潜力。它还揭示了几个需要进一步开发完善的模型缺点。